Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Increased Th17 response to myelin peptides in pediatric MS.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.
1,25-Dihydroxyvitamin D3 Suppresses TLR8 Expression and TLR8-Mediated Inflammatory Responses in Monocytes In Vitro and Experimental Autoimmune Encephalomyelitis In Vivo.
HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis.
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
Effects of Ferrofluid and Phytoalexin Spirobrassinin on Thioflavin-T-Based Fluorescence in Cerebrospinal Fluid of the Elderly and Multiple Sclerosis Patients.
Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.
Effects Of A Novel Orally Administered Calpain Inhibitor Snj-1945 On Immunomodulation And Neurodegeneration In A Murine Model Of Multiple Sclerosis.
[Biomarkers in multiple sclerosis].
Glutathione in multiple sclerosis: More than just an antioxidant?
Immunomodulatory Effects of Histone Deacetylase Inhibitors.
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.
Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum.
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.
Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder.
Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease.
Autophagy and autoimmunity crosstalks.
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis.
Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.

Pages